Insider Transactions in Q4 2024 at Nuvectis Pharma, Inc. (NVCT)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
4,500
+0.14%
|
$18,000
$4.65 P/Share
|
|
Dec 13
2024
|
Marlio Charles Mosseri > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
17,000
+0.65%
|
$68,000
$4.7 P/Share
|
|
Nov 19
2024
|
Enrique Poradosu Chief Science & Business Off |
BUY
Open market or private purchase
|
Direct |
2,000
+0.13%
|
$8,000
$4.99 P/Share
|
|
Nov 15
2024
|
Ron Bentsur Chairman & CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+0.61%
|
$80,000
$4.92 P/Share
|
|
Nov 07
2024
|
Michael J. Carson Vice President, Finance |
SELL
Open market or private sale
|
Direct |
2,755
-3.04%
|
$22,040
$8.16 P/Share
|